Van Lanschot Kempen Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.9M | Buy |
489,860
+222,605
| +83% | +$29.3M | 0.47% | 32 |
|
|
2026
Q1 | $37.2M | Sell |
267,255
-447
| -0.2% | -$62.6K | 0.33% | 53 |
|
|
2025
Q4 | $32.9M | Buy |
267,702
+3,200
| +1% | +$389K | 0.28% | 59 |
|
|
2025
Q3 | $29.4M | Sell |
264,502
-5,096
| -2% | -$579K | 0.26% | 71 |
|
|
2025
Q2 | $29.9M | Sell |
269,598
-57,692
| -18% | -$6.14M | 0.28% | 66 |
|
|
2025
Q1 | $36.7M | Sell |
327,290
-1,350
| -0.4% | -$139K | 0.38% | 56 |
|
|
2024
Q4 | $30.4M | Sell |
328,640
-174,174
| -35% | -$15.7M | 0.3% | 77 |
|
|
2024
Q3 | $42.2M | Sell |
502,814
-46,174
| -8% | -$3.52M | 0.43% | 65 |
|
|
2024
Q2 | $37.7M | Buy |
548,988
+31,332
| +6% | +$2.09M | 0.42% | 66 |
|
|
2024
Q1 | $37.9M | Buy |
517,656
+22,526
| +5% | +$1.73M | 0.47% | 64 |
|
|
2023
Q4 | $40.1M | Buy |
495,130
+16,505
| +3% | +$1.28M | 0.56% | 56 |
|
|
2023
Q3 | $35.9M | Buy |
478,625
+209,731
| +78% | +$16.1M | 0.66% | 46 |
|
|
2023
Q2 | $20.7M | Buy |
268,894
+63,149
| +31% | +$5.04M | 0.37% | 86 |
|
|
2023
Q1 | $17.1M | Hold |
205,745
| – | – | 0.32% | 95 |
|
|
2022
Q4 | $17.7M | Sell |
205,745
-68,103
| -25% | -$5.39M | 0.51% | 73 |
|
|
2022
Q3 | $16.9M | Sell |
273,848
-52,793
| -16% | -$3.33M | 0.68% | 55 |
|
|
2022
Q2 | $20.2M | Sell |
326,641
-70,901
| -18% | -$4.39M | 0.73% | 52 |
|
|
2022
Q1 | $23.6M | Buy |
397,542
+54,939
| +16% | +$3.51M | 0.72% | 56 |
|
|
2021
Q4 | $24.9M | Sell |
342,603
-522
| -0.2% | -$36K | 0.77% | 50 |
|
|
2021
Q3 | $24M | Sell |
343,125
-19,856
| -5% | -$1.39M | 0.86% | 37 |
|
|
2021
Q2 | $25M | Buy |
362,981
+2,397
| +0.7% | +$160K | 0.89% | 38 |
|
|
2021
Q1 | $23.3M | Buy |
360,584
+14,814
| +4% | +$955K | 1.07% | 34 |
|
|
2020
Q4 | $20.1M | Buy |
345,770
+62,378
| +22% | +$3.76M | 1.17% | 35 |
|
|
2020
Q3 | $17.9M | Buy |
283,392
+62,340
| +28% | +$4.32M | 1.36% | 23 |
|
|
2020
Q2 | $17M | Sell |
221,052
-16,245
| -7% | -$1.24M | 1.24% | 35 |
|
|
2020
Q1 | $17.7M | Sell |
237,297
-197,621
| -45% | -$13.7M | 1.48% | 10 |
|
|
2019
Q4 | $28.3M | Sell |
434,918
-1,184
| -0.3% | -$77.1K | 1.77% | 8 |
|
|
2019
Q3 | $27.6M | Buy |
436,102
+55,590
| +15% | +$3.63M | 2.2% | 3 |
|
|
2019
Q2 | $25.7M | Sell |
380,512
-20,923
| -5% | -$1.38M | 2.23% | 2 |
|
|
2019
Q1 | $26.1M | Buy |
401,435
+27,555
| +7% | +$1.83M | 2.37% | 1 |
|
|
2018
Q4 | $23.4M | Buy |
373,880
+3,890
| +1% | +$272K | 2.6% | 3 |
|
|
2018
Q3 | $28.6M | Buy |
369,990
+46,690
| +14% | +$3.53M | 2.29% | 3 |
|
|
2018
Q2 | $22.9M | Buy |
+323,300
| New | +$22.8M | 1.71% | 17 |
|
Other funds holding GILD
Van Lanschot Kempen Investment Management's GILD Position: Q2 2026 in Review
Van Lanschot Kempen Investment Management increased its Gilead Sciences (GILD) stake by 83% in Q2 2026, buying an estimated $29.3M and bringing the position to 489,860 shares worth $61.9M. The position accounts for 0.47% of the portfolio, ranked #32.
Van Lanschot Kempen Investment Management first reported a position in GILD in Q2 2018 and has held it in 33 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Van Lanschot Kempen Investment Management held 489,860 shares of Gilead Sciences worth $61.9M as of Q2 2026.
- Van Lanschot Kempen Investment Management bought 222,605 Gilead Sciences shares in Q2 2026, an estimated $29.3M.
- Gilead Sciences made up 0.47% of Van Lanschot Kempen Investment Management's portfolio in Q2 2026, its #32 holding.
- Van Lanschot Kempen Investment Management first reported a position in Gilead Sciences in Q2 2018 and has held it in 33 quarters since.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.